Latest posts by Mick Ferris (see all)
- Council Tax Bill for Rochford agreed for 2020/2021 - 19/02/2020
- It happened today – on this day in history – February 19 - 19/02/2020
- Jailed Basildon drug dealer’s designer gear confiscated - 18/02/2020
The Research and Development (R&D) department at Basildon Hospital currently contributes to over 60 studies that benefit patients and the wider NHS.
Medical research plays an essential role in developing new treatments, devices and methods of managing disease. By constantly striving to improve the effectiveness of existing treatments we will be able to provide better care to our patients, not just at Basildon but across our hospital group.
Recently, the R&D team hosted an open day to showcase the great research the hospital supports and invited staff and patients to come along to find out how this research improves the current and future health and care of our local population.
Perry Curley is one patient currently taking part in a clinical research trial, FLAIR. FLAIR (Front-Line therapy in CLL) trials new therapies in patients with previously untreated chronic lymphocytic leukaemia (CLL).
Perry said: “My family and I have seen a significant improvement in my health, all thanks to the work of our hospital and other healthcare researchers. It is essential that these trials and others continue so we can make improvements to treatments and make them available to all who need them.”
Ashley Solieri, associate director of research and development at Basildon Hospital added: “It was excellent to see Perry doing so well and to see other patients and our staff showing such an interest in our research activity. Without our patients agreeing to take part, we would not be able to support the many studies that we do.
“Our team is passionate about improving outcomes for our patients and contributing to evidence based treatments and healthcare delivery of the future.”
One other important study that the R&D team are currently supporting is GLAD (Genetic Links to Anxiety and Depression).
Research has shown that 30-40 per cent of the risk of depression and anxiety is genetic. Taking part in the GLAD study will help researchers to understand these genetic links and enable more effective treatments to be developed for patients who suffer with anxiety and depression.
If you would like to take part, participation is simple and you can register by following the instructions at www.gladstudy.org.uk